Fundraising FoxAprecia Pharmaceuticals
Langhorne, US · Delaware corporation · 2 known investors
Find your way into Aprecia Pharmaceuticals
Sign up to see every warm intro you have to Aprecia Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aprecia Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DW
Donald WetherholdExecutive
MR
Michael RohlfsExecutive
DF
David FurnissExecutive
RW
Robert WillifordExecutive
Board
LG
Lawrence GlassmannBoard director
JE
James EvansBoard director
EP
Etienne PeroldBoard director
ET
E Thomas AringtonBoard director
Investors · 2
Deerfield Management CompanyreportedNew Yorkvia Jonathan Leff · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Hercules Capital, Inc.reportedSan Mateo
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$117.7M disclosed across 2 rounds · 2015–2016
▶$79MraisedJan 2016 · 20 investors · PharmaceuticalsRule 506(b)
▶$79MraisedJan 2016 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Etienne PeroldDirector
- Michael RolhfsExecutive Officer
- David FurnissExecutive Officer
- Robert WillifordExecutive Officer
- James EvansDirector
- Lawrence GlassmannDirector
- E Thomas AringtonDirector
- Donald WetherholdExecutive Officer
- Jonathan LeffDirector
- Offering amount
- $84M
- Amount sold
- $79M
- Sales commissions
- $3.2M
- Placement agents
- MTS Securities, LLC
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.8MraisedAug 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$38.8MraisedAug 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- E Thomas AringtonDirector
- Donald WetherholdExecutive Officer
- Michael RohlfsExecutive Officer
- Lawrence GlassmannDirector
- David FurnissExecutive Officer
- Robert WillifordExecutive Officer
- James EvansDirector
- Etienne PeroldDirector
- Offering amount
- $52M
- Amount sold
- $38.8M
- Minimum investment
- $1
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Aprecia Pharmaceuticals's investors?
- Aprecia Pharmaceuticals's investors include Deerfield Management Company, Hercules Capital, Inc..
- How much funding has Aprecia Pharmaceuticals raised?
- Aprecia Pharmaceuticals has disclosed $117.7M raised across 2 rounds.
- Where is Aprecia Pharmaceuticals headquartered?
- Aprecia Pharmaceuticals is headquartered in Langhorne, US.